期刊文献+

幽门螺杆菌对克拉霉素耐药的分子基础 被引量:7

Molecular mechanism of the resistance of Helicobacter pylori to clarithromycin
暂未订购
导出
摘要 目的:探讨幽门螺杆菌(Helicobacter pylori,Hp)对克拉霉素耐药的分子基础。方法:采用E-test方法对35例Hp的临床分离株进行克拉霉素的MIC(minimal inhibitory concentration)检测,大于或等于8mg/L为耐药株, 按酚-氯仿方法提取Hp的DNA,PCR方法扩增23S rRNA基因中2047-2347之间的片段,对PCR产物进行序列分析,观察耐药株的基因突变情况,结果:与敏感菌(No33)序列比较,No13存在1个突变位点,即2289位点T变成了C(T2289C),No17存在2个突变位点,即G2224A、T2289C,No22存在3个突变位点,即G2224A、C2245T及T2289C,三株耐药Hp菌株的MIC值分别是:No13为8.0mg/L,No17为64mg/L,No22为大于256mg/L,随着耐药性的提高(表现在MIC值的升高),高耐药性菌株的突变位点多于低耐药注菌株的突变位点结论:与耐药有关的3个突变位点,G2224A、C2245T及T2289C,国内外未见报道。 AIM: To investigate the resistance mechanism of Hp to darithromycin. METHODS: With E-test method, we examined the minimal inhibitory concentration (MIC) to clarithromycin of 35 Hp dinical isolates. Resistance strains were defined when MIC ≥ 8 mg/L. Extract the DNA from the bacteria with the phenol- chloroform extraction method. Then amplify the fragments from 2 047 to 2 347 of 23 S rRNA gene. Gene sequence of the FCR products was analyzed to observe the mutation in the resistant Hp strains. RESULTS: Compared with susceptible strains, No13 strain contained one point mutation (T2289C), No17 had two point mutations (G2224A, T2289C) and No22 strain had 3 point mutations (G2224A, C2245T, T2289C). The MICs of the 3 resistant Hpisolates were as follows: No13 of 8.0 mg/L, No17 of 64 mg/L, No22 of > 256 mg/L. With increase of the resistance of Hp strains, the number of point mutations increased. C0NCLUSION: The point-mutations at 23 S rRNA gene re- spensible for Hp resistance to clarithromycin have not been reported in literature either at home or abroad, demon- strating that different mechanism of Hp resistance to clarithromvcin exists in different regions.
出处 《世界华人消化杂志》 CAS 2003年第10期1485-1487,共3页 World Chinese Journal of Digestology
  • 相关文献

参考文献8

二级参考文献91

  • 1刘之武,李平,谢蓓,杨萍.天津地区部分人群幽门螺杆菌感染现状[J].新消化病学杂志,1996,4(12):718-718. 被引量:2
  • 2[1]Parsonnet J,Friedman GD,Vandersteen DP.Helicobacter pylori infection and the risk of gastric carcinoma.New Engl J Med,1991; 325:1127 - 1131
  • 3[2]Parsonnet J,Hansen S,Rodriguez L.Helicobacter pylori infection and gastric lymphorma.NewEnglJMed,1994;330:1267-1271
  • 4[3]Wotherspoon AC.Gastric MALT lymphoma and Helicobacter pylori.Yale J Biol Med,1997;69:61-68
  • 5[4]The European Helicobacter pylori study Group (EHPSA).Current european concepts in the management of Helicobacter pylori infection-the Maastricht consensus report.Gut,1997;41:8 - 13
  • 6[7]Hansson LE,Nyren O,Hsing AW.The risk of stomach cancer in patients with gastric cancer or duodenal ulcer disease.New Engl J Med,1996; 335:242 - 249
  • 7[8]Cerutti PA.Oxy-radicals and cancer.Lancet,1994;344:862-863
  • 8[9]Renault B,Van den Broek M,Fodde R.Base transitions are the most frequent genetic changes at p53 in gastric cancer.Cancer Res,1993; 53:2614 - 2617
  • 9[10]Hongyo T,Buzard GS,Palli D.Mutations of the K-ras and p53 genes in gastric edenocarcinoma from a hign-incidence ragion around Florence,Italy.Cancer Res,1995; 55:2665 - 2672
  • 10[11]Imazeki F,Omata M,Nose H,Ohto M,Isono K.p53 gene mutations in gastric and esophagel Cancers.Gastroenterology,1992; 103:892 - 896

共引文献258

同被引文献76

引证文献7

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部